From: The role of macrophage subtypes and exosomes in immunomodulation
Macrophage types | Suggested roles | Markers | Different stimulator factors | References |
---|---|---|---|---|
M1 | Pro-inflammation, microbicidal effect, tumor resistance | IL-6, IL-10 (low), IL-12 (high), iNOS, CD80, CD86, CXCL9, CXCL10, CXCL11, CCL15, CCL20, CCL22, TLR2, TLR4, MHCII, TNF-α | IL-1, IL-6, IL-12, CXCL1-3, CXCL-5, CXCL8-10, CCL2, Type I IFN, IFN-γ, TNF-α, STAT1, iNOS, LPS, M-CSF, NF-κB, IRF5 miR-155, miR-125b, DNMT1, DNMT3b, HDAC3 | |
M2a | Allergy, profibrotic, anti-inflammatory, wound healing | IL-10, IL-1R, IL-27Rα, CCL1, CCL17, CCL18, CCL22, CD11b, CD45, CD206, YM1, RELMα, IGF1, DCIR, Stabilin 1, Factor XIII-A, Ly6C, TREM-2, DC-SIGN | IL-4, IL-10, IL-13, (PPAR-γ) | |
M2b | Th2 activation, immune regulation, promoting infection, tumor progression | IL-6, TNF-α, CD86, SPHK1 | IL-1β, LPS | |
M2c | Immunosuppression, phagocytosis, tissue repair, matrix remodeling | IL-10, CXCL13, CD163, CD206, CXCR4, TGF-β, MerTK, | IL-10, glucocorticoids IL-6, IL-10, TNF-α, TLR, | |
M2d | Tumor progression, angiogenesis, clearance of apoptotic tissue | IL-10, VEGF, TGF-β, | LPS |